Some of these are so new they were just synthed, some may have IPUAC's but no wikis and such. I'm no expert but I do know my pharmacology, so I can somewhat tell by structure(that and based on my previous experiences with most known noids in existence.) how one could potentially react. You bring up a good point with FAAH inhibitors, but MAO-B. Show me a noid with that potential and I'll believe it! Stuff like that is treading on some dangerous terrority!
the problem, as I am sure you are aware of, is instead of companies like Abbott, Pfizer and Bayer corp, inventing new structures with potential for pain killing and other medicinal benefits as it was in the industries infancy these labs are making designations for the soul purpose of skirting laws.
Here is a IUPAC for an MOA inhibitor:
N-(3,4-dichlorophenyl)-1-methyl-1H-indazole-5-carboxamide
PubMed article
Now here is the MAB-CHonga we were discussing.
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
granted these are nothing alike besides their indazole cores and carboxiamides, the article raised some concerns for me, with these newer ones coming out and our current knowledge of MOA inhibitors and their effects.
I've already noticed one carbox last year out of Germany with 4-dichlorophenyl, it even had a tail on it that is patented as a hepatitis treatment, so who knows what that ones is going to do. sure it will "fuck you up" if that is the goal, to just send you bodies regulatory systems into a chemical tailspin, not my idea of a good time.
Then we get to the issue of poor manufacturing techniques, as there is virtually no regulation in the industry (I tried people, but they just wouldn't have it) so we have things like Fluoridated tails not binding and even chained fluoro byproducts being left in the product which poses the unique threat of hypothalamus toxicity.
when poor manufacturing techniques and lack of regulation or third party testing (at least in the US) is common place there is no guarantee what you are getting is what the literature defines, if your product is full of precursors, some of which have their own effects, and byproducts it can be very detrimental to ones health, IMHO.